Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: Comparison of the efficacy of medikinet® retard and concerta®-a randomized, controlled, double-blind multicenter clinical crossover trial

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 5, 2011, Pages 445-454

  Döpfner, Manfred ^a   Ose, Claudia ^b   Fischer, Roland ^c   Ammer, Richard ^c   Scherag, André ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Department of Medice ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RELEASE; DRUG SYNTHESIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARENT; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SYMPTOM; TEACHER; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; METHYLPHENIDATE;

EID: 80155145195     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2010.0082     Document Type: Article

References (33)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
2. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E: Longacting medications for the hyperkinetic disorders: A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476-495, 2006.
3. Barkley RA: Attention-deficit hyperactivity disorder. Sci Am 279: 66-71, 1998.
4. Breuer D, Goertz-Dorten A, Rothenberger A, Döpfner M: Assessment of daily profiles of ADHD symptoms,ODD symptoms and adverse effects of ADHD medication by parent and teacher ratings. Eur Child Adolesc Psychiatry, 2011, in press.
5. Breuer D, Rettig K, Döpfner M: Die Erfassung von Aufmerksamkeitsund Verhaltensproblemen im Unterricht mit dem Fragebogen zur Verhaltensbeurteilung im Unterricht (FVU). [The assessment of attention and behavior problems in the classroom with the SKAMP] Diagnostica 55:11-19, 2009a.
6. Breuer D, Wolff Metternich T, Döpfner M: Die Erfassung von Merkmalen von Aufmerksamkeitsdefizit/Hyperaktivitätsstörungen (ADHS) anhand von Lehrerurteilen. Zur Validität und Reliabilität des FBB-HKS. [Assessment of ADHD symptoms using teacher ratings: Reliability and validity of the SCL-ADHD] Z Kinder Jugendpsychiatr Psychother 37:431-440, 2009b.
7. Collegium Internationale Psychiatriae Scalarum (ed): Internationale Skalen für Psychiatrie.[International Scales for Psychiatry]. Göttingen, Germany: Beltz Test; 1996.
8. Döpfner M, Banaschewski T, Schmidt J, Uebel H, Schmeck K, Gerber WD, Günter M, Knölker U, Gehrke M, Häßler F, Möhler E, Brünger M, Ose C, Fischer R, Poustka F, Lehmkuhl G, Rothenberger A: Lang-wirksames Methylphenidat bei Kindern mit Aufmerksamkeitsdefizit- Hyperaktivitätsstörungen. Eine multizentrische Studie.[Long-acting methylphenidate in children with ADHD-a multicenter study]. Nervenheilkunde22: 85-92, 2003.
9. Döpfner M, Breuer D, Wille N, Erhart M, Ravens-Sieberer U, the Bella Study Group: How often do children meet ICD-10/DSM-IV criteria of attention-deficit/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample- results of the BELLA study. Eur Child Adolesc Psychiatry 17(Suppl 1):59-70, 2008a.
10. Döpfner M, Gerber WD, Banaschewski T, Breuer D, Freisleder FJ, Gerber-Von Müller G, Günter M, Hässler F, Ose C, Rothenberger A, Schmeck K, Sinzig J, Stadler C, Uebel H, Lehmkuhl G: Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting. Eur Child Adolesc Psychiatry 13(Suppl 1):93-101, 2004.
11. Döpfner M, Görtz-Dorten A, Lehmkuhl G: Diagnostik-System für psychische Störungen nach ICD-10 und DSM-IV für Kinder- und Jugendliche (DISYPS-II). [Diagnostic system for mental disorders in children and adolescents according to ICD-10 and DSM-IV (DIYSPS-II)]. Bern, Switzerland: Huber; 2008b.
12. Duchateau L, Janssen P: Pairwise non-parametric non-inferiority tests in 3 .3 cross-over trials: Should we adjust for period? Stat Med 24:1525-1536, 2005.
13. Duchateau L, Janssen P, Straetemans R, Otoul C: Adjusting pairwise nonparametric equivalence hypothesis tests and confidence intervals for period effects in 3 .3 crossover trials. J Biopharm Stat 12:149-160, 2002.
14. Erhart M, Döpfner M, Ravens-Sieberer U, the Bella Study Group: Psychometric properties of two ADHD questionnaires: Comparing the Conners' scale and the FBB-HKS in the general population of German children and adolescents-results of the BELLA study. Eur Child Adolesc Psychiatry 17(Suppl 1):106-115, 2008.
15. Faraone SV, Biederman J, Spencer TJ, Aleardi M: Comparing the efficacy of medications for ADHD using meta-analysis. Med- GenMed 8:4, 2006.
16. Faraone SV, Buitelaar J: Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry 19:353-364, 2010.
17. Faraone SV, Sergeant J, Gillberg C, Biederman J: The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2:104-113, 2003.
18. Findling RL, Bukstein OG, Melmed RD, Lopez FA, Sallee FR, Arnold LE, Pratt RD: A randomized, double-blind, placebocontrolled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69:149-159, 2008.
19. Görtz-Dorten A, Döpfner M: Diagnose-Checklisten aus dem Diagnostik- System für Psychische Störungen im Kindes- und Jugendalter (DISYPS-II)-Gütekriterien und klinische Anwendung. [Diagnostic checklists from the diagnostic system for mental disorders in children and adolescents (DIYSPS-II]-psychometric criteria and clinical application]. Klinische Diagnostik und Evaluation 1:378-394, 2008.
20. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, Mcclellan J, Rue D, Shaw JA, Stock S, Kroeger K: Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 40:1352-1355, 2001.
21. Lopez F, Silva R, Pestreich L, Muniz R: Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs 5:545-555, 2003.
22. Maurer W, Hothorn L, Lehmacher W: Multiple comparisons in drug clinical trials and preclinical assays: A priori ordered hypothesis. In: Biometrie in der chemisch-pharmazeutischen Industrie [Biometrics in the Chemical-Pharmaceutical Industry]. Edited by Vollmar J. Stuttgart: Fischer; 1995; pp. 3-21.
23. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkom K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD: Once-aday Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107:e105, 2001.
24. Rösler M, Fischer R, Ammer R, Ose C, Retz W: A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 259:120-129, 2009.
25. Sonuga-Barke EJS, Coghill D, DeBacker M, Swanson J: Measuring methylphenidate response in attention-deficit/hyperactvity disorder: How are laboratory classroom-based measures related to parent ratings? J Child Adolesc Psychopharm 19:891-698, 2009.
26. Sonuga-Barke EJS, Swanson JM, Coghill D, DeCory HH, Hatch SJ: Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data. BMC Psychiatry 4:28, 2004.
27. Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH: A dose-response study of OROS methylphenidate in children with attention-deficit/ hyperactivity disorder. Pediatrics 112:e404, 2003.
28. Swanson JM: School Based Assessment and Interventions for ADD Students. Irvine, CA: K.C. Publishing; 1992.
29. Swanson JM, Agler D, Fineberg E, Wigal S, Flynn D, Fineberg K, Quintana Y, Talebi H: University of California, Irvine, Laboratory School Protocol for pharmacokinetic and pharmacodynamic studies. In: Ritalin: Theory and Practice. 2nd ed. Edited by L.L. Greenhill, B.B. Osman. New York: Mary Ann Liebert, Inc.; 2000, pp. 405-430.
30. Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group: A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics 113(3Pt1):e206-e216, 2004.
31. Wigal SB, Gupta S, Guinta D, Swanson JM: Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacological Bull 34:47-53, 1998.
32. Wilens T, Mcburnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper K, Lynch JM: Multisite, controlled trial of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 160:82-90, 2006.
33. Wolraich M, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G: Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 108:883-892, 2001.